A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis

Gynecologic Oncology

Volumn 92, Issue 3, 2004, Pages 936-940

  Grimm, Christoph ^a   Berger, Ingrid ^a   Tomovski, Caroline ^a   Zeillinger, Robert ^a   Concin, Nicole ^a   Leodolter, Sepp ^a   Koelbl, Heinz ^b   Tempfer, Clemens B ^c   Hefler, Lukas A ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Gene; Interleukin 1; Interleukin 1 receptor antagonist; Polymorphism; Vulvar cancer

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; CANCER PREVENTION; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; EXON; FEMALE; GENE CLUSTER; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; INTRON; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN FUNCTION; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA;

EID: 1342321830     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.039     Document Type: Article

References (20)

1. Dinarello C.A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 16:1998;457-499.
2. Arend W.P. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev. 13:2002;323-340.
3. Wolf J.S., Chen Z., Dong G., Sunwoo J.B., Bancroft C.C., Capo D.E.et al. IL (interleukin)-1alpha promotes nuclear factor-kappaB and AP-1-induced IL-8 expression, cell survival, and proliferation in head and neck squamous cell carcinomas. Clin. Cancer Res. 7:2001;1812-1820.
4. Fujiwaki R., Iida K., Nakayama K., Kanasaki H., Hata K., Katabuchi H.et al. Clinical significance of interleukin-1 receptor antagonist in patients with cervical carcinoma. Gynecol. Oncol. 89:2003;77-83.
5. Hirata A., Ogawa S., Kometani T., Kuwano T., Naito S., Kuwano M.et al. ZD1839 (Iressa) induces antiangiogenic effects through inhibition of epidermal growth factor receptor tyrosine kinase. Cancer Res. 62:2002;2554-2560.
6. Seppanen M., Vihko K.K. Activation of transcription factor NF-kappaB by growth inhibitory cytokines in vulvar carcinoma cells. Immunol. Lett. 74:2000;103-109.
7. Nicklin M.J., Weith A., Duff G.W. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics. 19:1994;382-384.
8. Pociot F., Molvig J., Wogensen L., Worsaae H., Nerup J.A. TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur. J. Clin. Invest. 22:1992;396-402.
9. di Giovine F.S., Takhsh E., Blakemore A.I., Duff G.W. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum. Mol. Genet. 1:1992;450.
10. Tarlow J.K., Blakemore A.I., Lennard A., Solari R., Hughes H.N., Steinkasserer A. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum. Genet. 91:1993;403-404.
11. Danis V.A., Millington M., Hyland V.J., Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin. Exp. Immunol. 99:1995;303-310.
12. Witkin S.S., Gerber S., Ledger W.J. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin. Infect. Dis. 34:2002;204-209.
13. Barber M.D., Powell J.J., Lynch S.F., Fearon K.C., Ross J.A. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br. J. Cancer. 83:2000;1443-1447.
14. El-Omar E.M., Carrington M., Chow W.H., McColl K.E., Bream J.H., Young H.A.et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature. 404:2000;398-402.
15. Jeremias J., Ledger W.J., Witkin S.S. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am. J. Obstet. Gynecol. 182:2000;283-285.
16. Hefler L.A., Ludwig E., Lebrecht A., Zeillinger R., Tong-Cacsire D., Koelbl H.et al. Polymorphisms of the interleukin-1 gene cluster and ovarian cancer. J. Soc. Gynecol. Investig. 9:2002;386-390.
17. Davidson E.J., Davidson J.A., Sterling J.C., Baldwin P.J., Kitchener H.C., Stern P.L. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res. 63:2003;400-403.
18. Rosenthal A.N., Ryan A., Hopster D., Jacobs I.J. p53 codon 72 polymorphism in vulval cancer and vulval intraepithelial neoplasia. Br. J. Cancer. 83:2000;1287-1290.
19. Unfried G., Tempfer C., Schneeberger C., Widmar B., Nagele F., Huber J.C. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil. Steril. 75:2001;683-687.
20. Hefler L.A., Tempfer C.B., Gregg A.R. Polymorphisms within the interleukin-1 beta gene cluster and preeclampsia. Obstet. Gynecol. 97:2001;664-668.